ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 386 filers reported holding ENCOMPASS HEALTH CORP in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,419 | -0.8% | 4,190 | 0.0% | 0.14% | +2.2% |
| Q2 2023 | $283,690 | +25.2% | 4,190 | +0.0% | 0.14% | +16.0% |
| Q1 2023 | $226,639 | -25.2% | 4,189 | -37.4% | 0.12% | -43.9% |
| Q3 2022 | $303,000 | -19.2% | 6,688 | +0.0% | 0.21% | -17.8% |
| Q2 2022 | $375,000 | -21.1% | 6,687 | +0.0% | 0.26% | -8.8% |
| Q1 2022 | $475,000 | +8.9% | 6,686 | +0.0% | 0.28% | +11.9% |
| Q4 2021 | $436,000 | -13.1% | 6,685 | +0.0% | 0.25% | -18.1% |
| Q3 2021 | $502,000 | -3.8% | 6,684 | +0.0% | 0.31% | -9.1% |
| Q2 2021 | $522,000 | -4.6% | 6,683 | 0.0% | 0.34% | -10.3% |
| Q1 2021 | $547,000 | -1.1% | 6,683 | +0.0% | 0.38% | -9.8% |
| Q4 2020 | $553,000 | +27.4% | 6,682 | +0.0% | 0.42% | +19.3% |
| Q3 2020 | $434,000 | +4.8% | 6,681 | +0.0% | 0.35% | +1.4% |
| Q2 2020 | $414,000 | -3.3% | 6,680 | +0.0% | 0.35% | -11.3% |
| Q1 2020 | $428,000 | -7.6% | 6,679 | 0.0% | 0.39% | +17.1% |
| Q4 2019 | $463,000 | – | 6,679 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 400,000 | $25,612,000 | 9.91% |
| REINHART PARTNERS, LLC. | 687,133 | $43,997,000 | 4.26% |
| RK Capital | 147,290 | $9,431,000 | 4.24% |
| HealthCor Management, L.P. | 1,525,809 | $97,698,000 | 4.18% |
| Integral Health Asset Management, LLC | 115,000 | $7,363,000 | 3.24% |
| Sivik Global Healthcare LLC | 32,500 | $7,733,000 | 3.05% |
| Copeland Capital Management, LLC | 635,514 | $40,692,000 | 2.48% |
| Rock Springs Capital Management LP | 815,000 | $52,184,000 | 2.16% |
| Endurant Capital Management LP | 55,614 | $3,561,000 | 1.61% |
| Advantage Alpha Capital Partners LP | 70,005 | $4,482,000 | 1.60% |